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Bovine rotavirus (BRV) V1005, like 34 further cell culture-adapted strains in a 6-year survey in Upper
Bavaria, Germany, is not a P12 but a P5 P-type rotavirus. The conclusion is based on dot blot hybridization
with P1-, P5-, and Pll-specific cDNAs, encompassing the VP8* region of major sequence diversity, and on PCR
using P1-, P5-, and P11-specific primer pairs derived from the VP5* region of VP4 (VP5* and VP8*,
respectively, are the larger and smaller tryptic cleavage products of VP4). Sequencing of the hyperdivergent
region of VP4 confirmed the close relatedness of BRV V1005 to BRV UK, the P5 prototype virus.
Group A bovine rotaviruses (BRVs) are a major infectious
cause of diarrhea in calves. Both outer capsid rotaviral pro-
teins, VP4 and VP7, can independently mediate active and
passive immunity (5). The neutralization specificity carried on
VP7 is referred to as the G serotype, and that carried on VP4
is referred to as the P serotype. By the unified serotyping
scheme (5), group A rotaviruses (RVs) are currently classified
into at least 14 G serotypes. RV G serotypes 6 and 10
predominate in cattle from Britain (17), Germany (2), Argen-
tina (1), the United States (14), and Japan (19). At least 12 P
types present among human and animal RV strains have been
reported (18). On the basis of serological analysis, at least
three P serotypes exist among BRV isolates (10, 18). A
possible fourth P serotype, represented by BRV 678 (17) and
BRV V1005 (3), has been identified serologically (18). BRV
V1005 and about 80 further BRV strains were isolated into cell
culture during a 6-year survey of calves with diarrhea from
dairy farms around Munich, Germany (2, 3). We were sur-
prised by the allocation of BRV V1005 to a new P12 serotype,
as our previous peptide mapping (3) and partial sequencing of
its VP4 (see below) indicated a close relatedness of V1005 to
BRV UK. To settle this apparent contradiction, we deter-
mined the P types of BRV V1005 and of 34 further BRV
isolates arbitrarily chosen from cell culture-adapted viruses in
this Bavarian survey.
Serology. Routine P serotyping of BRV remains problematic
because hyperimmunization of laboratory animals with RV
induces only a poor anti-VP4 antibody response. This was also
demonstrated in our study. Guinea pig hyperimmune sera were
raised against SAl1 x NCDV reassortant N-4 having VP4
from NCDV and VP7 from SAil (13) and DS-1 x UK
reassortant RV having VP4 from UK and VP7 from DS-1 (11).
High antibody titers were induced against the reassortant RV
DS-1 x UK, but the antisera failed to recognize BRV UK. In
contrast, one of two antisera raised against reassortant N-4
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specifically recognized BRV NCDV. This antiserum was cho-
sen to screen the German BRV isolates (Table 1); only four
isolates were neutralized by antiserum dilutions of 300 to 600,
which are 5- to 10-fold lower than neutralization titers against
P1 reference strain NCDV. We received from Snodgrass et al.
(18) their rabbit antisera raised against reassortant RVs rep-
resenting the different bovine P serotypes. However, with the
exception of the P1-specific antiserum, the neutralizing-anti-
body titers of these sera were too low to be of use in our
neutralization assay. This observation demonstrated indepen-
dently the difficulty of raising VP4-specific antisera with reas-
sortant RV as antigen.
Dot blot hybridization. Nucleic acid probes and PCR are
therefore more promising methods for P typing. A liquid
hybridization method using single-stranded RNA from cloned
BRV UK gene segment 4 demonstrated that BRV from
Britain showed P types related to that of P5 BRV UK (16).
Recently, dot blot hybridization assays for the typing of VP4
from BRV strains were described. cDNA probes were pre-
pared from the hyperdivergent regions (nucleotides 211 to
686) of gene segment 4 (15). Dot blot assays revealed P1, P5,
and P11 types in BRV field strains from North America, but
40% of the strains were untypeable (14). In our study, partial-
length gene 4 cDNA encompassing regions of major sequence
diversity (nucleotides 200 to 700) was prepared by PCR
amplification of gene segment 4 of BRV NCDV, UK, V1005,
and B223 as described previously (2). Primer 1 consisted of
bases 10 to 31 in the positive strand of gene 4 (5'CCCGG
GATCCATGGCTTCGCTCA'TTATAGAC), and primer 2
(5'CCCGGGATCCCTFTT7CCACAATGAAGTCTITTGA) was
derived from the complementary strand between bases 778 and
799 of gene 4. Both primers contained sequences for creating
a BamHI restriction site at their 5' end. The cDNAs corre-
sponding to the hypervariable region of VP4 from the different
BRV P types were cloned into the plasmid pUC19 and were
partially sequenced in both directions by the dideoxy chain
termination method by using the T7 polymerase sequencing
system with the M13 universal primers. This confirmed their
identity with sequences published for BRV NCDV and UK
(references 6 and 9 and data not shown).
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TABLE 1. Characterization of reference BRV isolates and cell
culture-adapted BRV isolates from a local survey conducted
in Germany by using the neutralization test,
dot blot hybridization, and PCR
Neutrali- Dot blot hybridization' with
Isolate code/yr G type' zation indicated cDNA probe PCRd
titerb NCDV UK B223 1005
Controls
NCDV 6 3,200 + - - - P1
UK 6 <100 - + - +
DS-1 x UK 2 <100 - + - +
N-4 3 12,800 + - - -
Survey isolates
V1005 10 <100 - + - + P5
627/77 6 100 - - - - P5
666/77 6(?) <100 - + - +
1429/77 6 <100 - - - - P5
10/78 10 400 - + - +
28/78 ? 200 - + - (+)
124/78 6 <100 - (+) - (+) P5
216/78 10 <100 - (+) - - P5
303/78 6 100 - + - + P5
314/78 10 <100 - + - +
601/78 6 100 - (+) - +
623/78 6 <100 - + - +
675/78 6 <100 - + - +
915/78 6 300 - + - + P5
955/78 6 <100 - + - +
1050/78 6 <100 - (+) - (+) P5
1150/78 6 < 100 - - - - P5
1237/78 6 <100 - + - (+)
1446/78 6 <100 - + - +
470/79 10 <100 - + - +
522/79 6 <100 - (+) - - P5
616/79 10 200 - + - +
638/79 10 <100 - (+) - (+) P5
718/79 10 <100 - + - +
734/79 10 <100 - + - (+) P5
770/79 6 <100 - + - (+)
437/80 6 (?) <100 - + - + P5
474/80 10 <100 - - - (+) P5
479/80 10 600 - (+) - +
468/82 6 <100 - + - +
125/83 6 <100 - - - - P5
274/83 6 NT - + - +
595/83 ? <100 - (+) - +
709/83 6 600 - + - +
"According to reference 2.
"Neutralization with the P1-specific antiserum. Preimmune titers, <50. NT,
not tested.
-, no hybridization; (+), weak hybridization; +, strong hybridization with
the indicated probe.
d Type determined by PCR as performed according to reference 8. When no
P type is given, the isolate was not tested.
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FIG. 1. Dot blot hybridization of the UK (A), NCDV (B), and
B223 (C) gene 4 PCR probes under high-stringency conditions. The
RV isolates in rows A to D and columns 1 to 12 are identified by their
code number and year of isolation: Al, 955/78; A2, 718/79; A3,
1237/78; A4, 616/79; A5, 470/79; A6, 718/79; A7, 638/79; A8, 522/79;
A9, 274/83; A10, 1334/78; All, 437/80; A12, 595/83; Bi, 915/78; B2,
734/79; B3, 28/78; B4, 479/80; B5, 303/78; B6, 770/79; B7, 10/78; B8,
474/80; B9, 216/78; B0, 124/78; BIl, 601/78; B12, 627/77; C1, 709/83;
C2, 1446/78; C3, 666/77; C4, 718/79; C5, 238/86; C6, 125/83; C7, 623/78;
C8, 675/78; C9, 1050/78; C10, 314/78; Cll, 1429/77; C12, 468/82;
Dl, 1150/78; D2, 993/83. (D) Control hybridization of the indicated
cDNA probes (P) against the indicated human and bovine reference
viruses.
In dot blot hybridization assays, the NCDV-specific cDNA
probe did not cross-hybridize with RNA from reference BRV
strains (V1005, B223, and UK) or any of the BRV isolates
from Germany (Fig. 1B). The DNA probe prepared from BRV
B223 hybridized specifically with RNA from BRV B223 but
with none of the reference BRV strains or the isolates from
Germany (Fig. IC). In contrast, cDNA prepared from VP4 of
BRV UK hybridized with 29 of the 34 German BRV isolates
(Fig. 1A). Notably, it hybridized also with RNA from BRV
V1005 (Fig. 1D). In fact, all German BRV isolates which
hybridized strongly with the UK-specific cDNA probe (Fig.
1A) also hybridized strongly with the V1005-specific cDNA
probe (data not shown).
PCR. Comparative analysis of the genes determining P
serotypes of BRVs allowed the development of PCR-based
assays (8). PCR assays revealed P1, P5, and P11 types in cell
culture-adapted BRV strains from a survey in Japan, with only
5% of the isolates being untypeable (19). The typing method
comprised three steps: reverse transcription of BRV RNA; a
first PCR amplification with common primers; and a second
PCR amplification with P1-, P5-, and P11-specific or G6- and
G10-specific primers as described previously (8). Similar self-
confirmatory heminested PCR typing assays have previously
been used for both human and animal RVs and tested for field
isolates. PCR was performed on BRV V1005 and a subgroup
of Bavarian BRV isolates which could not be typed by dot blot
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FIG. 2. Identification by PCR of the P types (lower panel) and G
types (upper panel) of the indicated BRV isolates. The second PCR
products were separated on a 2% agarose gel and stained with
ethidium bromide. DNA size markers at both sides are HaeIII-
digested 4X174. PCRs with G6 and G10 and P1, P5, and P11
reference viruses identify the positions of the diagnostic amplifica-
tion products.
indicative of the P5 type (Fig. 2). Note that the PCR assay of
Isegawa et al. (8) is based on sequences found in the VP5*
region of VP4, while the cDNA for dot blot hybridization
was derived from the VP8* region of VP4 (VP5* and VP8*,
respectively, are the larger and smaller tryptic cleavage
products of VP4). G typing by PCR (8) confirmed the G type
of these isolates determined previously by dot blot hybrid-
ization (compare Fig. 2 with Table 1).
Partial sequencing. To further characterize the relationship
between VP4s of BRV UK and V1005, the sequence of the
hyperdivergent region was determined for the V1005-specific
cDNA probe. The sequence between nucleotides 10 and 799
showed 90 and 95% sequence identity with the published (9)
homologous BRV UK sequence at the nucleotide and the
amino acid levels, respectively (Fig. 3). Note that BRV B641,
a further P5 BRV strain, also differs in this region from BRV
UK by about 10% at the nucleotide level (7).
Snodgrass et al. (18) have proposed a new P type (P12)
found in BRV isolates 678, WC3, and V1005. Despite a lack of
serological data, the three DNA-based P-typing methods,
however, unequivocally allocate V1005 to the P5 type.
In our survey of 34 German BRVs, 19 G6-P5 types (56%)
and 11 G10-P5 types (32%) were identified, while 4 strains
(12%) showed the P5 type but were of doubtful G type. P5 was
also the preponderant P type in BRVs from Japan (19), the
United States (14), and Britain (16). No P1 or P11 types were
detected in our survey. BRVs of the P1 type were found in 2
and 10% of Japanese and North American isolates, respec-
tively (14, 19). P1 types are rare in Australia (7) and Britain
(16). The currently available BRV vaccine strain (NCDV,
G6-P1) might thus be unsuitable in many areas of the world.
Cross-protection tests with calves implicated VP4 as an impor-
tant antigen in the active immune response to RV infection in
bovines (20). A G6-P5 combination may thus be a better
vaccine candidate.
Our data do not represent a true epidemiological surveil-
lance for a number of reasons. The survey was geographically
limited to the area of Upper Bavaria around Munich, Ger-
many. It was also limited in time to a 6-year period between
1977 and 1983. After introduction of dam vaccination with an
inactivated V1005-based vaccine (4), BRV isolates were no
longer collected. Note that the viruses investigated for their P
type were cell culture-adapted BRV strains and not viruses in
fecal samples (2). Since VP4 has been documented to be
associated with viral growth (12), cell culture-adapted BRVs
V 1005 MASLIYRQLL ANSYAVDLSD EIQSVGSEKN QRVTVNPGPF AQTGYAPVNW GPGEVNDSTV VQPVLDGPYQ PASFDLPVGN
UK (P5) ------ ------N---------G- ---- -------- -- -- --P-------
NCDV (P1) ---------- T---T-E---- EI-T-T -D N --- T- ---T -E-------- -TT-NP--SY
81 WMLLAPTGPG VVVEGTDNSG RWLSVILIEP GVTSETRTYT MFGSSKQVLV SNVSVSKWKF VEMMKTAVDG DYAEWGTLLS
-------R-- ---------- ---------- A- M --------V- ----DT---- ---V------ ----------
-------NA-- N-TN ---AT- N-QQVE --- L- -QQV- -T- --DSQT- DLS-QTQ-- N-SQH- S---
161 DTKLYGMKY GERLFIYEGE TPNATTKGYI VTNYASVEVR PYSDFYIISR SQESACTEYI NNGLPPIQNT RNVVPVAISS
--------- -R-------- F I--------- ---------- ---------- ---------- ----------
TP---V--H -GKIYT-N-- ------GY-S T--FDT-NMT A-C- PL A--AK----- ---------- --I---S-V-
241 RSIKPREVQA NEDIVVSKTS LWK
-N-VYTRA-P -Q-------- ---
FIG. 3. Sequence alignment of the hyperdivergent region of VP4 (amino acid positions 1 to 263) from BRV V1005 with the published sequence
(9) of P5 prototype BRV UK and the published sequence (6) of Pl prototype BRV NCDV.
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could be biased with respect to true field isolates. Note that a
true field survey from Britain showed nearly exclusively P5 type
BRV strains, as did our German survey (16).
Finally, we restate that a true P serotype must be defined by
a neutralizing antibody. DNA-based methods can be accepted
as proxy measures only if sufficient data from surveys
demonstrate the concordance of the two techniques. Lack of
appropriate antibody has precluded up to now such an
assessment.
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